vertex pharmaceuticals inc
(VRTX:NASDAQ GS)
VRTX
Industry Average
Profitability - vertex pharmaceuticals inc (VRTX)
|
Return on Assets Industry Comparison
-2.99%
|
Return on Equity Industry Comparison
-43.38%
|
|
|
Return on Capital Industry Comparison
-4.27%
|
Margin Analysis - vertex pharmaceuticals inc (VRTX)
|
Gross Margin Industry Comparison
70.61%
|
Levered Free Cash Flow Margin Industry Comparison
12.51%
|
|
|
EBITDA Margin Industry Comparison
-5.14%
|
SG&A Margin Industry Comparison
29.54%
|
Asset Turnover - vertex pharmaceuticals inc (VRTX)
|
Total Assets Turnover Industry Comparison
0.6x
|
Accounts Receivables Turnover Industry Comparison
6.6x
|
|
|
Fixed Assets Turnover Industry Comparison
4.2x
|
Inventory Turnover Industry Comparison
5.5x
|
Credit Ratios - vertex pharmaceuticals inc (VRTX)
|
Current Ratio Industry Comparison
3.8x
|
Quick Ratio Industry Comparison
3.5x
|
Long-Term Solvency - vertex pharmaceuticals inc (VRTX)
|
Total Debt/Equity Industry Comparison
75.7x
|
Total Liabilities/Total Assets Industry Comparison
59.2x
|
Growth Over Prior Year - vertex pharmaceuticals inc (VRTX)
|
Total Revenue Industry Comparison
-20.22%
|
Tangible Book Value Industry Comparison
96.83%
|
|
|
EBITDA Industry Comparison
-114.35%
|
Gross Profit Industry Comparison
-34.95%
|
|
|
Receivables Industry Comparison
-16.44%
|
Inventory Industry Comparison
-83.39%
|
|
|
Diluted EPS Before Extra Industry Comparison
-269.02%
|
Capital Expenditures Industry Comparison
127.28%
|
|
|
Cash From Ops. Industry Comparison
-40.25%
|
Levered Free Cash Flow Industry Comparison
328.84%
|
| Recently Viewed | |||
| VRTX:US | $78.48 USD | +0.05 |  |
| Company | Last | Change |
| Alkermes PLC | $33.00 USD | +1.25 |
| BioMarin Pharmaceutical Inc | $65.76 USD | +0.21 |
| Jazz Pharmaceuticals Plc | $63.00 USD | +1.47 |
| Onyx Pharmaceuticals Inc | $96.20 USD | +3.17 |
| Regeneron Pharmaceuticals Inc | $254.87 USD | -7.55 |
| View Industry Companies | ||
Industry Analysis
VRTX
Industry Average
| Valuation | VRTX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 12.1x |
|
| Price/Book | 23.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 10.9x |
|
Post a JobJobs
- St Petersburg, FL | Vertex PharmaceuticalsPosted: May 23
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 23
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 23
- San Diego, CA | Vertex PharmaceuticalsPosted: May 23
Sponsored Financial Commentaries
Sponsored Links
To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
